Editor's pick
Botulinum Toxin Type-A — Korean Brand Clinical Survey 2026
A journal-of-medicine reading of the Korean botulinum toxin type-A landscape in 2026 — what MFDS clearance distinguishes between Hutox, Nabota, Coretox, Meditoxin, Wonder-Tox, and Liztox, and how the senior Seoul houses sequence the unit co
Read the editorial →Pillars
Latest reading
Korean Aesthetic Medicine Statistics Survey 2026
A clinical-evidence reading of the Korean aesthetic-medicine landscape through KHIDI medical-tourism receipts, MFDS device clearance counts, MOHW physician lice
Clinical-EvidencePDLLA (Juvelook) vs Sculptra (PLLA) — A 2026 Korean Clinical Comparison
A journal-of-medicine reading of the two principal poly-lactic-acid biostimulators in 2026 — Juvelook (PDLLA, VAIM Global, MFDS-cleared 2020) and Sculptra (PLLA
RecoveryDowntime by Procedure — Clinical Survey 2026
A journal-of-medicine reading of what aesthetic-procedure downtime actually looks like in Seoul in 2026 — by procedure category, by recovery milestone, and by t
Clinical-EvidenceJuvelook (PDLLA) + MFU Combination — A Korean Clinical Reading
A journal-of-medicine reading of the Juvelook PDLLA microsphere booster stacked with microfocused ultrasound lifting in Korea in 2026 — what the published liter
Clinical-EvidenceKorean Aesthetic Medicine Decade — A Clinical Retrospective 2026
A journal-of-medicine reading of Korea's aesthetic-medicine decade — Rejuran 2014, Ultherapy 2015, Juvelook 2020, ASCE+ exosome 2024 — against MFDS clearance, t
Clinical-EvidenceKorean Laser Clinical Evidence Survey 2026
A clinical-evidence reading of the Korean laser landscape — picosecond, fractional CO2, IPL, pulsed-dye, Q-switched, and carbon toning — through the lens of MFD
Get Korea Aesthetic Journal in your inbox
A monthly editorial digest from the desk. No spam, never sold.